Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
NCT02942563
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Rectal Cancer
Interventions
DRUG:
FOLFOXIRI
Sponsor
RenJi Hospital